Literature DB >> 31053030

Self-Assembled Responsive Bilayered Vesicles with Adjustable Oxidative Stress for Enhanced Cancer Imaging and Therapy.

Jibin Song1, Lisen Lin2, Zhen Yang2, Rong Zhu1, Zijian Zhou2, Zhan-Wei Li3, Feng Wang4, Jingyi Chen4, Huanghao Yang1, Xiaoyuan Chen2.   

Abstract

In the present study, we report the development of magnetic-plasmonic bilayer vesicles assembled from iron oxide-gold Janus nanoparticles (Fe3O4-Au JNPs) for reactive oxygen species (ROS) enhanced chemotherapy. The amphiphilic Fe3O4-Au JNPs were grafted with poly(ethylene glycol) (PEG) on the Au surface and ROS-generating poly(lipid hydroperoxide) (PLHP) on the Fe3O4 surface, respectively, which were then assembled into vesicles containing two closely attached Fe3O4-Au NPs layers in opposite directions. The self-assembly mechanism of the bilayered vesicles was elucidated by performing a series of numerical simulations. The enhanced optical properties of the bilayered vesicles were verified by the calculated results and experimental data. The vesicles exhibited enhanced T2 relaxivity and photoacoustic properties over single JNPs due to the interparticle magnetic dipole interaction and plasmonic coupling. In particular, the vesicles are pH responsive and disassemble into single JNPs in the acidic tumor environment, activating an intracellular biochemical reaction between the grafted PLHP and released ferrous ions (Fe2+) from Fe3O4 NPs, resulting in highly efficient local ROS generation and increased intracellular oxidative stress. In combination with the release of doxorubicin (DOX), the vesicles combine ROS-mediated cytotoxicity and DOX-induced chemotherapy, leading to greatly improved therapeutic efficacy than monotherapies. High tumor accumulation efficiency and fast vesicle clearance from the body were also confirmed by positron emission tomography (PET) imaging of radioisotope 64Cu-labeled vesicles.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31053030     DOI: 10.1021/jacs.8b13902

Source DB:  PubMed          Journal:  J Am Chem Soc        ISSN: 0002-7863            Impact factor:   15.419


  15 in total

1.  Recent Advances in Molecular Imaging with Gold Nanoparticles.

Authors:  Mathilde Bouché; Jessica C Hsu; Yuxi C Dong; Johoon Kim; Kimberly Taing; David P Cormode
Journal:  Bioconjug Chem       Date:  2019-11-13       Impact factor: 4.774

Review 2.  Harnessing the Therapeutic Potential of Extracellular Vesicles for Biomedical Applications Using Multifunctional Magnetic Nanomaterials.

Authors:  Letao Yang; Kapil D Patel; Christopher Rathnam; Ramar Thangam; Yannan Hou; Heemin Kang; Ki-Bum Lee
Journal:  Small       Date:  2022-02-08       Impact factor: 15.153

3.  A COF-based nanoplatform for highly efficient cancer diagnosis, photodynamic therapy and prognosis.

Authors:  Peng Gao; Mengzhen Wang; Yuanyuan Chen; Wei Pan; Ping Zhou; Xiuyan Wan; Na Li; Bo Tang
Journal:  Chem Sci       Date:  2020-06-16       Impact factor: 9.825

4.  Yolk-shell nanovesicles endow glutathione-responsive concurrent drug release and T1 MRI activation for cancer theranostics.

Authors:  Dahai Liu; Zijian Zhou; Xinyu Wang; Hongzhang Deng; Lin Sun; Haixin Lin; Fei Kang; Yong Zhang; Zhantong Wang; Weijing Yang; Lang Rao; Kuikun Yang; Guocan Yu; Jianshi Du; Zheyu Shen; Xiaoyuan Chen
Journal:  Biomaterials       Date:  2020-03-16       Impact factor: 12.479

5.  Stimuli-Responsive Plasmonic Assemblies and Their Biomedical Applications.

Authors:  Qinrui Fu; Zhi Li; Fengfu Fu; Xiaoyuan Chen; Jibin Song; Huanghao Yang
Journal:  Nano Today       Date:  2020-11-08       Impact factor: 20.722

Review 6.  Ferrite Nanoparticles-Based Reactive Oxygen Species-Mediated Cancer Therapy.

Authors:  Shancheng Yu; Huan Zhang; Shiya Zhang; Mingli Zhong; Haiming Fan
Journal:  Front Chem       Date:  2021-04-27       Impact factor: 5.221

Review 7.  Gold-based Inorganic Nanohybrids for Nanomedicine Applications.

Authors:  Xianguang Ding; Dan Li; Jiang Jiang
Journal:  Theranostics       Date:  2020-07-02       Impact factor: 11.556

Review 8.  Stimulus-Responsive Nanomedicines for Disease Diagnosis and Treatment.

Authors:  Gengqi Liu; Jonathan F Lovell; Lei Zhang; Yumiao Zhang
Journal:  Int J Mol Sci       Date:  2020-09-02       Impact factor: 5.923

9.  Carrier-free prodrug nanoparticles based on dasatinib and cisplatin for efficient antitumor in vivo.

Authors:  Lu Yang; Jiaxi Xu; Zheng Xie; Faquan Song; Xin Wang; Rupei Tang
Journal:  Asian J Pharm Sci       Date:  2021-09-08       Impact factor: 6.598

Review 10.  Design of Magnetic Nanoplatforms for Cancer Theranostics.

Authors:  Wangbo Jiao; Tingbin Zhang; Mingli Peng; Jiabao Yi; Yuan He; Haiming Fan
Journal:  Biosensors (Basel)       Date:  2022-01-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.